Aspirin may interact with cells’ DNA modifications to alter breast cancer outcomes

Aspirin may interact with cells’ DNA modifications to alter breast cancer outcomes AUGUST 12, 2019 New findings suggest that women with specific DNA characteristics in certain areas of the genome may live longer if they take aspirin before they are diagnosed with breast cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer… Read more »